methylprednisolone has been researched along with Macrophage Activation Syndrome in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 13 (43.33) | 24.3611 |
| 2020's | 16 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas, AS; Abdel-Aziz, TM; Alsaqabi, F; Gouda, W; Islam, MA; Moshrif, A | 1 |
| Chan, TM; Chang, ES; Wu, CE; Yu, HH | 1 |
| He, L; Jin, Z; Liu, M; Wang, Y; Wang, Z; Zhang, R | 1 |
| Deng, W; Huang, Z; Li, T; Wang, Y; Yi, G; Zheng, S | 1 |
| Fukazawa, R; Itoh, Y; Kaneko, S; Narazaki, H; Ota, H; Shimizu, M; Tanabe, Y; Tsuno, K; Watanabe, M; Yamanishi, S | 1 |
| Aguiar, F; Azevedo, AC; Brito, I; Ganhão, S; Martins, FR; Rodrigues, M | 1 |
| Cowley, S; Ramakrishnan, S | 1 |
| Akita, H; Goda, K; Hoshijima, M; Kenzaka, T; Yachie, A | 1 |
| Deng, G; Luo, H; Xie, Y; Zeng, F; Zuo, X | 1 |
| Ahmad, NS; Lim, CH; Tan, CL; Yahaya, MH | 1 |
| Cho, S; Kwon, HW; Oh, KJ; Seo, JW | 1 |
| Bose, N; Chowdhury, K; Pal, P; Poddar, A; Saha, A | 1 |
| Bathia, J; Giri, PP; Nandi, A; Pal, P; Roy, M | 1 |
| Gupta, A; Jindal, AK; Johnson, N; Pilania, RK; Prithvi, A; Rawat, A; Singh, S; Suri, D; Vignesh, P | 1 |
| Das, S; Dubey, S; Pandit, A; Ray, BK | 1 |
| Gill, A; Gupta, A | 1 |
| Kanegane, H; Kong, P; Tang, X; Yan, X; Yang, X; Yao, H; Zhang, X; Zhang, Z; Zhao, Q; Zhao, X | 1 |
| Banday, A; Bansal, R; Jindal, AK; Loganathan, S; Mohanandia, B; Patra, N; Pulipaka, S; Singh, S; Sudhakar, M | 1 |
| Băicuş, C; Balea, M; Tulbă, D | 1 |
| Akagi, K; Arai, K; Harayama, S; Kawai, T; Oana, S; Onodera, M; Watanabe, N; Yokoyama, M | 1 |
| Komagata, Y | 1 |
| Kundu, R; Mukherjee, D; Niyogi, P; Pal, P | 1 |
| Jin, J | 1 |
| de Benedictis, FM; Jorini, M; Martini, G; Piccinini, P; Zulian, F | 1 |
| Campos, LM; Jesus, AA; Lotito, AP; Omori, CH; Porta, G; Silva, CA | 1 |
| Abe, H; Endo, H; Kaburaki, M; Kaneko, K; Kawai, S; Kusunoki, Y; Muraoka, S; Tanaka, N; Yamamoto, T | 1 |
| Ahluwalia, J; Ahmed, N; Chandrakasan, S; Das, R; Rawat, A; Sachdeva, MU; Singh, S; Suri, D; Varma, N | 1 |
| Kumar, S; Rajam, L | 1 |
| Araujo, DB; Bonfa, E; Borba, EF; Campos, LM; Pereira, RM; Shinjo, SK; Silva, CA | 1 |
| Chiang, BL; Lee, JH; Lin, CI; Lin, YT; Wang, LC; Yang, YH; Yu, HH | 1 |
4 review(s) available for methylprednisolone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
Topics: Antirheumatic Agents; Cytokine Release Syndrome; Cytokines; Dexamethasone; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Methylprednisolone; Respiratory Distress Syndrome | 2022 |
Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.
Topics: Cytokines; Female; Glucocorticoids; Humans; Interleukin-18; Interleukin-6; Macrophage Activation Syndrome; Methylprednisolone; Neopterin; Prednisolone; Pulse Therapy, Drug; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Still's Disease, Adult-Onset; Young Adult | 2020 |
Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.
Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Arthritis, Juvenile; Child, Preschool; Cidofovir; Combined Modality Therapy; Cyclosporine; Female; Humans; Macrophage Activation Syndrome; Methylprednisolone; Pneumonia, Viral; Radiography, Thoracic | 2020 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome and
Topics: Antirheumatic Agents; Connective Tissue Diseases; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; gamma-Globins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Methotrexate; Methylprednisolone; Pulse Therapy, Drug | 2013 |
26 other study(ies) available for methylprednisolone and Macrophage Activation Syndrome
| Article | Year |
|---|---|
Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Topics: Adult; Cyclosporine; Dexamethasone; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Methylprednisolone | 2021 |
Effectiveness of a modified doxorubicin-etoposide-methylprednisolone regimen for the treatment of refractory or relapsed macrophage activation syndrome in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Macrophage Activation Syndrome; Methylprednisolone; Salvage Therapy | 2022 |
Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
Topics: Adult; Azetidines; Female; Humans; Macrophage Activation Syndrome; Methylprednisolone; Panniculitis; Purines; Pyrazoles; Skin Neoplasms; Sulfonamides; Young Adult | 2022 |
Clinical Course and Cytokine Profile of Systemic Juvenile Idiopathic Arthritis in a Patient with Trisomy 21.
Topics: Arthritis, Juvenile; Cytokines; Disease Progression; Down Syndrome; Humans; Macrophage Activation Syndrome; Methylprednisolone | 2023 |
Anakinra and hepatotoxicity in pediatric rheumatology: a case series.
Topics: Arthritis, Juvenile; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Exanthema; Ferritins; Fever; Humans; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Macrophage Activation Syndrome; Male; Methylprednisolone; Rheumatology | 2023 |
Macrophage activation syndrome in a patient with systemic lupus erythematosus.
Topics: Adult; Female; Humans; Immunoglobulins, Intravenous; Lupus Erythematosus, Systemic; Macrophage Activation; Macrophage Activation Syndrome; Methylprednisolone; Syndrome | 2019 |
Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report.
Topics: Adult; Female; Humans; Hypertension, Pulmonary; Macrophage Activation Syndrome; Methylprednisolone; Scimitar Syndrome; Still's Disease, Adult-Onset | 2019 |
Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus with sensorineural hearing loss in a young male patient.
Topics: Administration, Intravenous; Adolescent; Aftercare; Bone Marrow; Diagnosis, Differential; Exanthema; Fever; Glucocorticoids; Hearing Loss, Sensorineural; Humans; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Methylprednisolone; Pancytopenia; Treatment Outcome | 2020 |
A case of life-threatening valvulitis mimicking infective endocarditis in systemic juvenile idiopathic arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Juvenile; Child; Diagnosis, Differential; Echocardiography; Endocarditis; Female; Humans; Macrophage Activation Syndrome; Methylprednisolone; Mitral Valve Insufficiency; Radiography, Thoracic | 2020 |
Macrophage activation syndrome in pediatrics: 10 years data from an Indian center.
Topics: Arthritis, Juvenile; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Forecasting; Glucocorticoids; Hospitals, Pediatric; Humans; Immunosuppressive Agents; Incidence; India; Macrophage Activation Syndrome; Male; Methylprednisolone; Retrospective Studies | 2020 |
Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Topics: Child; Child, Preschool; Coronary Aneurysm; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; India; Infant; Infliximab; Macrophage Activation Syndrome; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Prednisolone; Pulse Therapy, Drug; Tertiary Healthcare; Thrombocytopenia | 2021 |
MRI negative myeloradiculoneuropathy unmasking systemic lupus erythematosus.
Topics: Cyclophosphamide; Diagnosis, Differential; Fatal Outcome; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Magnetic Resonance Imaging; Methylprednisolone; Spinal Cord Diseases; Young Adult | 2021 |
Multisystem Inflammatory Syndrome in a Child with Scrub Typhus and Macrophage Activation Syndrome.
Topics: Adolescent; Azithromycin; Biomarkers; Child; COVID-19; Female; Fever; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Macrophage Activation Syndrome; Methylprednisolone; Pandemics; SARS-CoV-2; Scrub Typhus; Systemic Inflammatory Response Syndrome | 2021 |
UNC13D mutation in a patient with juvenile polymyositis with recurrent macrophage activation syndrome.
Topics: Adolescent; Antirheumatic Agents; Autoantibodies; Bone Marrow Examination; Cyclosporine; Etoposide; Homozygote; Humans; Macrophage Activation Syndrome; Male; Membrane Proteins; Methylprednisolone; Mutation, Missense; Patient Care Planning; Polymyositis; Positron Emission Tomography Computed Tomography; Remission Induction; Topoisomerase II Inhibitors; Treatment Outcome | 2021 |
Tapering Doses of Methylprednisolone Pulse in the Treatment of Macrophage Activation Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.
Topics: Arthritis, Juvenile; Cyclosporine; Heart Rate; Humans; Macrophage Activation Syndrome; Methylprednisolone | 2021 |
Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
Topics: Adult; Diagnosis, Differential; Drug Resistance; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Methylprednisolone; Prednisolone; Remission Induction | 2018 |
A case of macrophage activation syndrome developing in a patient with chronic granulomatous disease-associated colitis.
Topics: Anti-Inflammatory Agents; Child, Preschool; Colitis; Combined Modality Therapy; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Macrophage Activation Syndrome; Male; Methylprednisolone; Prognosis | 2014 |
Macrophage activation syndrome in Kawasaki disease.
Topics: Anti-Inflammatory Agents; Child, Preschool; Humans; Immunoglobulins, Intravenous; Macrophage Activation Syndrome; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome | 2014 |
A continuous infusion of etoposide and doxorubicin for refractory MAS management.
Topics: Doxorubicin; Etoposide; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infusions, Intravenous; Macrophage Activation Syndrome; Methylprednisolone; Still's Disease, Adult-Onset; Topoisomerase II Inhibitors; Young Adult | 2016 |
Macrophage activation syndrome as trigger event for systemic lupus erythematosus in children.
Topics: Anti-Inflammatory Agents; Child; Female; Humans; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Methylprednisolone; Prednisone | 2009 |
Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome?
Topics: Acute Disease; Adolescent; Cell Proliferation; Child; Cytokines; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Macrophages; Male; Methylprednisolone; Pancreatitis; Retrospective Studies; Severity of Illness Index; T-Lymphocytes | 2010 |
Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration.
Topics: Adult; Antirheumatic Agents; Etanercept; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Inflammation Mediators; Macrophage Activation Syndrome; Male; Methylprednisolone; Plasma Exchange; Pulse Therapy, Drug; Receptors, Tumor Necrosis Factor; Still's Disease, Adult-Onset; Treatment Outcome; Tumor Necrosis Factor-alpha; Up-Regulation | 2010 |
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.
Topics: Arthritis, Juvenile; Child; Child, Preschool; Disease Progression; Female; Glucocorticoids; Humans; India; Macrophage Activation Syndrome; Male; Methylprednisolone | 2012 |
Posterior reversible encephalopathy syndrome (PRES/RPLS) during pulse steroid therapy in macrophage activation syndrome.
Topics: Child; Glucocorticoids; Humans; Macrophage Activation Syndrome; Male; Methylprednisolone; Posterior Leukoencephalopathy Syndrome; Pulse Therapy, Drug | 2011 |
Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Child; Dyspnea; Female; Hemoglobins; Hemoptysis; Hemorrhage; Humans; Hypoxia; Lung Diseases; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Methylprednisolone; Prednisone; Pulmonary Alveoli; Respiration, Artificial; Retrospective Studies; Sepsis; Statistics, Nonparametric; Young Adult | 2012 |
Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Topics: Adolescent; Antiphospholipid Syndrome; Arthritis, Juvenile; Autoimmune Diseases; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Macrophage Activation Syndrome; Male; Methylprednisolone; Retrospective Studies; Treatment Outcome | 2012 |